(Q41610792)

5 October 2017

title

Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171). (English)

1 reference

5 October 2017

Gottlieb P

1

1 reference

5 October 2017

Wandall T

series ordinal

2

1 reference

5 October 2017

Overø KF

series ordinal

3

1 reference

5 October 2017

language of work or name

English

0 references

publication date

1 September 1980

1 reference

Acta Psychiatrica Scandinavica

5 October 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

5 October 2017

volume

62

1 reference

5 October 2017

issue

3

1 reference

5 October 2017

page(s)

236-244

1 reference

Pharmacology of a new phthaline (Lu 10-171), with specific 5-HT uptake inhibiting properties

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1980.TB00611.X

Preliminary studies of the kinetics of citalopram in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1980.TB00611.X

Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1980.TB00611.X

Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1980.TB00611.X

10.1111/J.1600-0447.1980.TB00611.X

21 January 2018

Identifiers

DOI

1 reference

5 October 2017

1 reference